Literature DB >> 34295632

Reply: Herpes zoster keratouveitis with hypopyon and hyphema.

Katherine Seng Boon Hwei1.   

Abstract

Entities:  

Year:  2020        PMID: 34295632      PMCID: PMC8259517          DOI: 10.4103/tjo.tjo_35_20

Source DB:  PubMed          Journal:  Taiwan J Ophthalmol        ISSN: 2211-5056


× No keyword cloud information.
Dear Editor, The authors thank Prof. Mahmood Dhahir Al-Mendalawi for his interest and knowledgeable comment on our published manuscript entitled “Herpes zoster keratouveitis with hypopyon and hyphema” in the January–March issue of the Taiwan Journal of Ophthalmology. Prof Mahmood had suggested for the two of the herpes zoster ophthalmicus (HZO) cases in our article to be screened for human immunodeficiency virus (HIV) infection. We understand that the concern was raised due to the susceptibility of HIV-infected patients to contract various viral infections including herpes zoster infection. Recommendation for young patients presenting with HZO to be screened for HIV was highlighted by Osahon and Onunu.[1] Our article acknowledged both of the elderly patients as immunocompetent in the discussion and highlighted another similar case reported in a young patient with HIV infection.[2] We regrettably did not specifically include in our article that both of our patients were tested negative for HIV. We hope we clarify the doubt raised in the letter to the editor and we welcome any future feedback.

Financial support and sponsorship

Nil.

Conflicts of interest

The author declares that there are no conflicts of interests of this paper.
  2 in total

1.  Acute panuveitis with haemorrhagic hypopyon as a presenting feature of acquired immunodeficiency syndrome (AIDS).

Authors:  J Biswas; T K Samanta; H N Madhavan; N Kumarasamy; S Solomon
Journal:  Indian J Ophthalmol       Date:  2000-12       Impact factor: 1.848

2.  Ocular disorders in patients infected with the human immunodeficiency virus at the University of Benin Teaching Hospital, Benin City, Nigeria.

Authors:  A I Osahon; A N Onunu
Journal:  Niger J Clin Pract       Date:  2007-12       Impact factor: 0.968

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.